01 1Zhejiang Bamboo Pharmaceuticals
01 1GABAPENTIN
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-04-08
Pay. Date : 2024-03-07
DMF Number : 37761
Submission : 2023-01-06
Status : Active
Type : II
20
Zhejiang Bamboo Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GABAPENTIN, with a corresponding US DMF Number 37761.
Remarkably, this DMF maintains an Active status since its submission on January 06, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 08, 2024, and payment made on March 07, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
